One-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?

Uytun, SPolat, SETabakçi, SÖCinel, GEmiralioglu, NYalçin, EKiper, NSen,Altintas, DUÇokugras, HKilinç, AAYazan, HÇollak, AUzuner, SÜnal, GYilmaz, AÇelik, SDamadoglu, EIrmak, IDemir, EÖztürk, GBasaran, EBingöl, ASapan, NAslan, ATAsfuroglu, PHarmanci, KKöse, MHangül, MÖzdemir, AÖzcan, GGayretli, ZGKeskin, ÖYüksel, HÖzdogan, STopal, EÇaltepe, GCan, DEkren, PKKiliç, MSüleyman, AEyüboglu, TSPekcan, SÇobanoglu, NÇakir, EÖzçelik, UDogru, D2025-04-102025-04-100903-1936http://hdl.handle.net/20.500.14701/43133EnglishOne-Year Follow-Up of Cystic Fibrosis Patients Who Cannot Reach the Modulator Therapies Although Having Indications: What are Their Losses?Meeting Abstract1399-3003